Go Pro
→ NNVC on Alert: FDA Validation and Outperform Rating! (From Equiscreen) (Ad)tc pixel Free CVS Stock Alerts

CVS Health (CVS) Competitors

CVS Health logo
$93.60 -0.89 (-0.94%)
As of 11:01 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CVS vs. AMZN, WMT, CI, ELV, and HUM

Should you buy CVS Health stock or one of its competitors? CVS Health's main competitors and comparable companies include Amazon.com (AMZN), Walmart (WMT), Cigna Group (CI), Elevance Health (ELV), and Humana (HUM). Companies are selected based on similarities in market, industry, and size.

How does CVS Health compare to Amazon.com?

Amazon.com (NASDAQ:AMZN) and CVS Health (NYSE:CVS) are related large-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Amazon.com has higher revenue and earnings than CVS Health. Amazon.com is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amazon.com$716.92B3.73$77.67B$12.4319.95
CVS Health$402.07B0.30$1.77B$3.7824.92

Amazon.com has a net margin of 17.44% compared to CVS Health's net margin of 1.18%. Amazon.com's return on equity of 18.00% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Amazon.com17.44% 18.00% 8.97%
CVS Health 1.18%13.12%3.95%

In the previous week, Amazon.com had 376 more articles in the media than CVS Health. MarketBeat recorded 410 mentions for Amazon.com and 34 mentions for CVS Health. Amazon.com's average media sentiment score of 0.90 beat CVS Health's score of 0.76 indicating that Amazon.com is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amazon.com
256 Very Positive mention(s)
66 Positive mention(s)
47 Neutral mention(s)
24 Negative mention(s)
15 Very Negative mention(s)
Positive
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

72.2% of Amazon.com shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 8.9% of Amazon.com shares are held by insiders. Comparatively, 0.9% of CVS Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Amazon.com has a beta of 1.44, indicating that its stock price is 44% more volatile than the broader market. Comparatively, CVS Health has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

Amazon.com presently has a consensus price target of $323.26, suggesting a potential upside of 30.34%. CVS Health has a consensus price target of $107.24, suggesting a potential upside of 13.85%. Given Amazon.com's higher probable upside, equities analysts plainly believe Amazon.com is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amazon.com
0 Sell rating(s)
3 Hold rating(s)
56 Buy rating(s)
0 Strong Buy rating(s)
2.95
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Summary

Amazon.com beats CVS Health on 13 of the 16 factors compared between the two stocks.

How does CVS Health compare to Walmart?

CVS Health (NYSE:CVS) and Walmart (NASDAQ:WMT) are related large-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Walmart pays an annual dividend of $0.99 per share and has a dividend yield of 0.9%. CVS Health pays out 70.4% of its earnings in the form of a dividend. Walmart pays out 35.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has raised its dividend for 4 consecutive years and Walmart has raised its dividend for 53 consecutive years.

Walmart has a net margin of 3.00% compared to CVS Health's net margin of 1.18%. Walmart's return on equity of 21.83% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CVS Health1.18% 13.12% 3.95%
Walmart 3.00%21.83%7.80%

In the previous week, Walmart had 11 more articles in the media than CVS Health. MarketBeat recorded 45 mentions for Walmart and 34 mentions for CVS Health. Walmart's average media sentiment score of 0.79 beat CVS Health's score of 0.76 indicating that Walmart is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive
Walmart
16 Very Positive mention(s)
13 Positive mention(s)
12 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

CVS Health has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Walmart has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

80.7% of CVS Health shares are held by institutional investors. Comparatively, 26.8% of Walmart shares are held by institutional investors. 0.9% of CVS Health shares are held by company insiders. Comparatively, 0.1% of Walmart shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Walmart has higher revenue and earnings than CVS Health. CVS Health is trading at a lower price-to-earnings ratio than Walmart, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVS Health$402.07B0.30$1.77B$3.7824.92
Walmart$713.16B1.20$21.89B$2.7738.93

CVS Health currently has a consensus target price of $107.24, indicating a potential upside of 13.85%. Walmart has a consensus target price of $131.88, indicating a potential upside of 22.29%. Given Walmart's stronger consensus rating and higher possible upside, analysts clearly believe Walmart is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96
Walmart
0 Sell rating(s)
4 Hold rating(s)
32 Buy rating(s)
3 Strong Buy rating(s)
2.97

Summary

Walmart beats CVS Health on 15 of the 19 factors compared between the two stocks.

How does CVS Health compare to Cigna Group?

Cigna Group (NYSE:CI) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Cigna Group has higher earnings, but lower revenue than CVS Health. Cigna Group is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.27$5.96B$24.1711.84
CVS Health$402.07B0.30$1.77B$3.7824.92

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 80.7% of CVS Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by company insiders. Comparatively, 0.9% of CVS Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cigna Group presently has a consensus price target of $337.10, indicating a potential upside of 17.84%. CVS Health has a consensus price target of $107.24, indicating a potential upside of 13.85%. Given Cigna Group's higher probable upside, research analysts clearly believe Cigna Group is more favorable than CVS Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Cigna Group pays out 25.8% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

In the previous week, CVS Health had 22 more articles in the media than Cigna Group. MarketBeat recorded 34 mentions for CVS Health and 12 mentions for Cigna Group. Cigna Group's average media sentiment score of 0.86 beat CVS Health's score of 0.76 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
6 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

Cigna Group has a net margin of 2.27% compared to CVS Health's net margin of 1.18%. Cigna Group's return on equity of 19.75% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.27% 19.75% 5.34%
CVS Health 1.18%13.12%3.95%

Cigna Group has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

Summary

Cigna Group beats CVS Health on 10 of the 19 factors compared between the two stocks.

How does CVS Health compare to Elevance Health?

Elevance Health (NYSE:ELV) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

Elevance Health has higher earnings, but lower revenue than CVS Health. Elevance Health is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.46$5.66B$22.5018.65
CVS Health$402.07B0.30$1.77B$3.7824.92

Elevance Health has a net margin of 2.47% compared to CVS Health's net margin of 1.18%. Elevance Health's return on equity of 14.64% beat CVS Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
CVS Health 1.18%13.12%3.95%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by company insiders. Comparatively, 0.9% of CVS Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.6%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and CVS Health has raised its dividend for 4 consecutive years.

Elevance Health presently has a consensus price target of $440.90, indicating a potential upside of 5.05%. CVS Health has a consensus price target of $107.24, indicating a potential upside of 13.85%. Given CVS Health's stronger consensus rating and higher possible upside, analysts plainly believe CVS Health is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Elevance Health has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

In the previous week, CVS Health had 17 more articles in the media than Elevance Health. MarketBeat recorded 34 mentions for CVS Health and 17 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.99 beat CVS Health's score of 0.76 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
10 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Elevance Health beats CVS Health on 11 of the 19 factors compared between the two stocks.

How does CVS Health compare to Humana?

Humana (NYSE:HUM) and CVS Health (NYSE:CVS) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.8%. Humana pays out 33.5% of its earnings in the form of a dividend. CVS Health pays out 70.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVS Health has increased its dividend for 4 consecutive years. CVS Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CVS Health has higher revenue and earnings than Humana. CVS Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.36$1.19B$10.5737.12
CVS Health$402.07B0.30$1.77B$3.7824.92

Humana has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

CVS Health has a net margin of 1.18% compared to Humana's net margin of 0.88%. CVS Health's return on equity of 13.12% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.88% 11.20% 3.94%
CVS Health 1.18%13.12%3.95%

In the previous week, CVS Health had 21 more articles in the media than Humana. MarketBeat recorded 34 mentions for CVS Health and 13 mentions for Humana. Humana's average media sentiment score of 1.10 beat CVS Health's score of 0.76 indicating that Humana is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVS Health
17 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Positive

92.4% of Humana shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.9% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Humana presently has a consensus price target of $403.91, indicating a potential upside of 2.95%. CVS Health has a consensus price target of $107.24, indicating a potential upside of 13.85%. Given CVS Health's stronger consensus rating and higher possible upside, analysts clearly believe CVS Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
1 Sell rating(s)
15 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.43
CVS Health
0 Sell rating(s)
1 Hold rating(s)
22 Buy rating(s)
0 Strong Buy rating(s)
2.96

Summary

CVS Health beats Humana on 12 of the 19 factors compared between the two stocks.

Get CVS Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVS vs. The Competition

Export
MetricCVS HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$120.29B$9.91B$7.21B$23.14B
Dividend Yield2.78%2.61%2.57%3.58%
P/E Ratio24.8834.23273.5528.53
Price / Sales0.305.02705.7520.21
Price / Cash6.42126.2577.7134.34
Price / Book1.595.3810.454.71
Net Income$1.77B$313.45M$3.49B$1.07B
7 Day Performance-1.29%2.20%-0.38%-1.28%
1 Month Performance-2.98%-0.51%-0.13%-4.09%
1 Year Performance28.23%17.28%19.26%9.27%

CVS Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVS
CVS Health
4.6379 of 5 stars		$93.60
-0.9%		$107.24
+14.6%		+28.6%$119.76B$402.07B24.77300,000
AMZN
Amazon.com
4.9586 of 5 stars		$252.89
+0.2%		$323.26
+27.8%		+7.3%$2.73T$716.92B20.341,576,000
WMT
Walmart
4.7062 of 5 stars		$105.97
+0.1%		$131.88
+24.5%		+4.3%$840.94B$713.16B38.272,100,000
CI
Cigna Group
4.701 of 5 stars		$280.07
+0.7%		$337.10
+20.4%		-2.8%$74.22B$274.90B11.6267,700
ELV
Elevance Health
4.2216 of 5 stars		$417.08
+5.1%		$440.90
+5.7%		+35.9%$90.71B$199.13B18.5997,100

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:CVS) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners
“This is the Perfect Tech Stock”
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
The national debt just passed $39 trillion
The U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...
US Gold Bureau | Sponsoredtc pixel
This Gold Explorer Is Approaching Its Biggest Milestone Yet
A little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...
Wall Street Logic | Sponsoredtc pixel
NNVC on Alert: FDA Validation and Outperform Rating!
NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...
Equiscreen | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel